Abingdon Health Plc (AIM:ABDX)

Abingdon Health Statistics

Total Valuation

Abingdon Health has a market cap or net worth of GBP 29.25 million. The enterprise value is 28.36 million.

Market Cap	29.25M
Enterprise Value	28.36M

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Abingdon Health has 433.39 million shares outstanding. The number of shares has increased by 20.32% in one year.

Current Share Class	251.07M
Shares Outstanding	433.39M
Shares Change (YoY)	+20.32%
Shares Change (QoQ)	+6.78%
Owned by Insiders (%)	6.09%
Owned by Institutions (%)	39.24%
Float	213.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.47
PB Ratio	5.52
P/TBV Ratio	11.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.31
EV / Sales	3.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.08

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.19.

Current Ratio	1.76
Quick Ratio	1.58
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-0.29
Interest Coverage	-49.78

Financial Efficiency

Return on equity (ROE) is -90.48% and return on invested capital (ROIC) is -56.24%.

Return on Equity (ROE)	-90.48%
Return on Assets (ROA)	-37.59%
Return on Invested Capital (ROIC)	-56.24%
Return on Capital Employed (ROCE)	-67.74%
Revenue Per Employee	67,976
Profits Per Employee	-27,540
Employee Count	124
Asset Turnover	1.17
Inventory Turnover	9.71

Taxes

Income Tax	-81,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.15% in the last 52 weeks. The beta is 0.19, so Abingdon Health's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-16.15%
50-Day Moving Average	6.62
200-Day Moving Average	6.46
Relative Strength Index (RSI)	45.22
Average Volume (20 Days)	120,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abingdon Health had revenue of GBP 8.43 million and -3.42 million in losses. Loss per share was -0.01.

Revenue	8.43M
Gross Profit	3.74M
Operating Income	-4.33M
Pretax Income	-3.50M
Net Income	-3.42M
EBITDA	-3.72M
EBIT	-4.33M
Loss Per Share	-0.01

Balance Sheet

The company has 1.92 million in cash and 1.03 million in debt, giving a net cash position of 890,000 or 0.00 per share.

Cash & Cash Equivalents	1.92M
Total Debt	1.03M
Net Cash	890,000
Net Cash Per Share	0.00
Equity (Book Value)	5.30M
Book Value Per Share	0.01
Working Capital	2.21M

Cash Flow

In the last 12 months, operating cash flow was -3.18 million and capital expenditures -327,000, giving a free cash flow of -3.51 million.

Operating Cash Flow	-3.18M
Capital Expenditures	-327,000
Free Cash Flow	-3.51M
FCF Per Share	-0.01

Margins

Gross margin is 44.32%, with operating and profit margins of -51.38% and -40.51%.

Gross Margin	44.32%
Operating Margin	-51.38%
Pretax Margin	-41.48%
Profit Margin	-40.51%
EBITDA Margin	-44.17%
EBIT Margin	-51.38%
FCF Margin	n/a

Dividends & Yields

Abingdon Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.32%
Shareholder Yield	-20.32%
Earnings Yield	-11.67%
FCF Yield	-12.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Abingdon Health has an Altman Z-Score of -0.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.69
Piotroski F-Score	3